Yihong Tang
Chinese Academy of Sciences
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yihong Tang.
Journal of Pharmaceutical and Biomedical Analysis | 2011
Huihui Liu; Ke Wang; Yihong Tang; Zhaolin Sun; Longhai Jian; Zhixiong Li; Bin Wu; Chenggang Huang
The in vivo and in vitro metabolism of mangiferin was systematically investigated. Urine, plasma, feces, contents of intestinal tract and various organs were collected after oral administration of mangiferin to healthy rats at a dose of 200mg/kg body weight. For comparison, mangiferin was also incubated in vitro with intestinal flora of rats. With the aid of a specific and sensitive liquid chromatography coupled with electrospray ionization tandem hybrid ion trap mass spectrometry (LC-ESI-IT-MS(n)), a total of thirty-three metabolites of mangiferin were detected and their structures were tentatively elucidated on the basis of the characteristics of their precursor ions, product ions and chromatographic retention times. The biotransformation pathways of mangiferin involved deglycosylation, dehydroxylation, methylation, glycosylation, glucuronidation and sulfation.
Biomedical Chromatography | 2008
Chunhui Ma; L. Wang; Yihong Tang; Mingsong Fan; Hongbin Xiao; Chenggang Huang
Rhizoma Anemarrhenae (Zhimu in Chinese), the dried rhizome of Anemarrhena asphodeloides Bge. (Fam. Liliaceae), is a well-known traditional Chinese medicinal herb and has been used clinically in China for centuries to cure various diseases. However, like other traditional Chinese medicines, the effective constituents of this medicine, especially the assimilation and metabolites in vivo, which are very important to show their effects, have not been systematically studied. In this paper, solid-phase extraction and liquid chromatography-atmospheric pressure chemical ionization mass spectrometry technologies were used to study the constituents absorbed into rat urine and their metabolites after oral administration of Rhizoma Anemarrhenae decoction. A total of 11 compounds, including two xanthones, three of their metabolites and six steroidal saponins, were identified in rat urine sample. They were neomangiferin (1), glucuronide and monomethyl conjugate of mangiferin (2), mangiferin (3), monomethyl conjugate of mangiferin (4), dimethyl conjugate of mangiferin (5), timosaponin N or timosaponin E1 (6), timosaponin BII (7), timosaponin BIII (8), anemarrhenasaponin I or anemarrhenasaponin II (9), timosaponin AII (10) and timosaponin AIII (11). The results would efficaciously narrow the potentially active compounds range in Rhizoma Anemarrhenae decoction, and pave a helpful way for follow-up mechanism of action research.
Biomedical Chromatography | 2008
Chunhui Ma; Mingsong Fan; Yihong Tang; Zhixiong Li; Zhaolin Sun; Guan Ye; Chenggang Huang
Huangbai-Zhimu herb-pair (HBZMHP) is a widely used Chinese traditional medicine formula in treating various diseases; however, its active components have remained unknown. In this paper, serum chemistry and combined high-performance liquid chromatography (HPLC), diode-array detection and mass-spectrometry (MS) techniques were used to study the constituents of HBZMHP extract absorbed into rat serum after oral administration. A total of nine characteristic HPLC peaks in the TIC chromatograms were identified as magnoflorine (1), menisperine (2), palmatine (3), berberine (4), timosaponin N or timosaponin E1 (5), timosaponin D (6), timosaponin BIII, anemarsaponin C or xilingsaponin B (7) timosaponin BII (8) and timosaponin AIII (9). All of the identified peaks were constituents of HBZMHP extract. The results narrow the range of active compounds to be found in HBZMHP extract, and pave the way for the follow-up action mechanism research.
Journal of Pharmaceutical and Biomedical Analysis | 2011
Luying Chen; Zhixiong Li; Yihong Tang; Xiaolan Cui; Ronghua Luo; Shanshan Guo; Yongtang Zheng; Chenggang Huang
In vivo and in vitro metabolites of calycosin-7-O-β-D-glucopyranoside in rats were identified using a specific and sensitive high performance liquid chromatography-tandem mass spectrometry (HPLC-MS(n)) method. The parent compound and twelve metabolites were found in rat urine after oral administration of calycosin-7-O-β-D-glucopyranoside. The parent compound and six metabolites were detected in rat plasma. In heart, liver, spleen, lung and kidney samples, respectively, six, eight, seven, nine and nine metabolites were identified, in addition to the parent compound. Three metabolites, but no trace of parent drug, were found in the rat intestinal flora incubation mixture and feces, which demonstrated cleavage of the glycosidic bond of the parent compound in intestines. The main phase I metabolic pathways of calycosin-7-O-β-D-glucopyranoside in rats were deglycosylation, dehydroxylation and demethylation reactions; phase II metabolism included sulfation, methylation, glucuronidation and glycosylation (probably). Furthermore, two metabolites commonly found in rat urine, plasma and tissues were isolated from feces and characterized by NMR. The antiviral activities of the metabolite calycosin against coxsackie virus B₃ (CVB₃) and human immunodeficiency virus (HIV) were remarkably stronger than those of calycosin-7-O-β-D-glucopyranoside.
Biomedical Chromatography | 2010
Guan Ye; Yihong Tang; Guang-Xin Xia; Zhaolin Sun; Zhixiong Li; Chenggang Huang
To profile the anti-Coxsackie virus B3 constituents of Radix Astragali, an HPLC-DAD-MS(n) analytical method, combined with an in vivo test, has been developed to identify the constituents of the active part, which has been demonstrated to have potency to inhibit the proliferation of virus in cardiac muscle, alleviate infraction in heart and elevate the survival rate of the animal. By comparing their retention time and MS data with those obtained from the authentic compounds and the published data, a total of 19 compounds, including 11 isoflavonoids and eight saponins, were identified, among which one pterocarpane glucoside was reported for the first time. The present study provides an approach to rapidly screening bioactive constituents in traditional Chinese medicines.
Chemistry & Biodiversity | 2010
Guan Ye; Yihong Tang; Gui-Yun Wang; Zhixiong Li; Haiyan Zhu; Chunhui Ma; Zhao-Ling Sun; Chenggang Huang
A rapid, sensitive, and specific method by high‐performance liquid chromatography (HPLC) coupled to diode‐array detection (DAD) and tandem mass spectrometry (MS) techniques was developed for the identification of absorbed constituents and their metabolites in rats after the oral administration of a Chai‐Huang decoction (CHD), which consists of Bupleurum chinense and Scutellaria baicalensis in the proportion 1 : 1 (w/w). By comparing their retention times and MS data with those of authentic compounds and published data, a total of 14 compounds were identified in the CHD samples. In addition, eleven and seven compounds were characterized in the urine and serum samples of the rats, respectively. The results indicated that the main absorbed constituents were chrysin‐6‐C‐arabinosyl‐8‐C‐glucoside, chrysin‐6‐C‐glucosyl‐8‐C‐arabinoside, baicalin, wogonin‐5‐O‐glucoside, oroxylin A‐7‐O‐glucuronide, wogonoside, saikosaponin A, saikosaponin C, saikosaponin D, baicalein, and wogonin. These compounds might be responsible for the curative effects of the CHD. The findings demonstrated that the proposed method could be used to rapidly and simultaneously analyze and screen the multiple absorbed bioactive constituents in a formula of traditional Chinese medicines (TCM). This is very important not only for the pharmaceutical discovery process and the quality control of crude drugs but also to explain the mechanisms of action of TCM.
Journal of Analytical Chemistry | 2013
Zhiwen Zhang; Bin Wu; Yihong Tang; Zaijun Li; Zhao-Ling Sun; Luying Chen; Y. B. Ji; Chunhui Ma; Cheng Gang Huang
To characterize of the constituents in rat urine after oral administration of Radix Astragali decoction, a HPLC-DAD-MS/MS technique had been developed. Urine collected from 0 to 24 h, after administration, was purified using a C18 solid-phase extraction cartridge, and then detected by an on-line MS/MS detector. By comparing the retention times and MS/MS data with those obtained from authentic compounds and the published data, a total of 11 compounds including six flavonoids, one dipeptide, one triterpenoid and three of their metabolites in urine were identified. Compounds daidzein, genistein, quercetin, L-asparamide-D-phenylalanine, 4,2′,4′-trihydroxychalcone, Astragaloside-IV, daidzein sulfate, and kaempferol sulfate were for the first time detected by HPLC-MS/MS technique in urine. The present research results success-fully narrowed the range of effective constituents to be found in Astragalus membranaceus and would be useful for the following action mechanism research of this traditional Chinese medicine in treating various diseases.
Archive | 2012
Chenggang Huang; Bin Wu; Shuyun Liu; Shuang Liu; Zhixiong Li; Longhai Jian; Yihong Tang; Zhaolin Sun; Ke Wang
Rheum palmatum L., one of the commonly used Traditional Chinese Medicines (TCMs), which is called Dahuang in Chinese, has been successfully used in China for thousands of years. The crude material of R. palmatum called rhubarb was widely used as laxative to treat constipation. Furthermore, it has various other pharmacological actions, such as antibacterial [1, 2], anti-inflammatory [3, 4], antiviral [5], anti-angiogenic [6], antioxidative [7], immunomodulatory [8], protecting effects in rat with chronic renal failure [9] and antidiabetic effects on diabetic mice [10]. Although many investigations have been conducted in the fields of pharmacology, clinical trials, and phytochemistry about rhubarb, researchers still do not know what its effective constituents are, how many compounds are absorbed into blood after intragastric administration of the decoction, and what the fate of the decoction in the body is. The limited knowledge about the metabolism of rhubarb decoction restricts the deeper pharmacological mechanism study and wider clinical use of rhubarb. It was well accepted that TCMs expressed its effects through multi-components and multitargets. Rapid, sensitive and selective analytical method is needed to simultaneous determine of multiple components of TCMs in biological matrix with low concentrations. In recent years, HPLC/ESI/MSn has been proved to be a modern and powerful method for the identification of compounds in biosamples or TCM extracts [11, 12]. Metabolism of rhubarb has been reported [13], but data on pharmacokinetics are scanty. So, our interest was to utilize a solid phase extraction (SPE) and HPLC/ESI/MSn techniques for the detection of potentially active compounds in urine, plasma and tissue samples and for the
Journal of Pharmaceutical and Biomedical Analysis | 2007
Hui Wang; Guan Ye; Chunhui Ma; Yihong Tang; Mingsong Fan; Zhixiong Li; Chenggang Huang
Biomedical Chromatography | 2006
Yihong Tang; Haiyan Zhu; Yuanyuan Zhang; Chenggang Huang